Discover
INDP
Indaptus Therapeutics, Inc.
2.94
2 x 2.14
2 x 3.72
bid
ask
-
0.06
2.00%
2 @ 04:00 PM
2.92 -0.02 (0.68%)
| Ytd | 1.03% | |
| 1y | -73.63% |
2.88
day range
3.00
0.92
52 week range
13.40
| Open | 2.97 | Prev Close | 3.00 | Low | 2.88 | High | 3.00 | Mkt Cap | 391.73M |
| Vol | 50.76K | Avg Vol | 1.02M | EPS | -12.70 | P/E | N/A | Forward P/E | -0.64 |
| Beta | 1.13 | Short Ratio | 0.54 | Inst. Own | 6.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 2.59 | 200-d Avg | 2.53 | 1yr Est | 8.50 |
| Income Statement | |||
| Operating Expenses | 2.16M | ||
| Research and Development Expense | 491.13K | ||
| Selling, General and Administrative Expense | 1.67M | ||
| Operating Income | -2.16M | ||
| Net Income | -2.54M | ||
| Net Income Common Stock | -2.54M | ||
| Net Income Common Stock (USD) | -2.54M | ||
| Consolidated Income | -2.54M | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.23 | ||
| Earning Before Interest & Taxes (EBIT) | -2.54M | ||
| Earning Before Interest & Taxes (USD) | -2.54M | ||
| Weighted Average Shares | 10.96M | ||
| Weighted Average Shares Diluted | 10.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.50M | ||
| Cash and Equivalents (USD) | 1.50M | ||
| Current Assets | 2.18M | ||
| Total Assets | 2.18M | ||
| Current Liabilities | 933.00K | ||
| Total Liabilities | 933.00K | ||
| Accumulated Retained Earnings (Deficit) | -83.83M | ||
| Shareholders Equity | 1.25M | ||
| Shareholders Equity (USD) | 1.25M | ||
| Trade and Non-Trade Payables | 933.00K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.01M | ||
| Net Cash Flow from Operations | -7.01M | ||
| Share Based Compensation | 227.18K | ||